|
Background:
The HCV epidemic in the United States, with focus on both Pennsylvania and Ohio, iGreene K., Scholz K., Gast, C., & Grinnell As an urgent, pressing public health concern, disproportionately affecting minority groups who encounter numerous barriers to care. Key factors contributing to these disparities include biased clinical decision-making, structural barriers, and socioeconomic inequities. A significant study indicates that African American/Black patients are approximately 30% less likely to be tested for hepatitis C compared to their white counterparts with similar risk factors.
Effectiveness:
Our team recognizes the importance of service delivery options that meet the needs of our patients in various treatment settings and decrease racial disparities with HCV testing and treatment. We are implementing a “test and treat” model utilizing mobile outreach and Cepheid machines to provide same-day hepatitis C testing and treatment, specifically targeting underserved populations. Our initiatives include engagement with faith-based and community minority organizations to enhance community engagement and access to care. We prioritize individualized education tailored to the unique needs of diverse populations, emphasizing patient-centered care.
Our marketing efforts are strategically designed to reach communities that are often overlooked, ensuring our messages resonate with their specific needs. Our team is actively advocating for the removal of structural barriers—such as the requirements for sobriety, specific fibrosis scores or genotypes—to improve eligibility for treatment. We understand that when it comes to effective patient care, representation matters. We have implemented interventions so that our provider population reflects the patient populations that we serve to better meet the needs of these underserved communities.
Conclusion:
In conclusion, while our efforts are making strides in reducing disparities, further research is essential to develop effective strategies to increase community engagement for Hepatitis C and HIV treatment/prevention in our underserved and disenfranchised minority communities. Addressing these disparities will contribute significantly to the overall goal of eliminating hepatitis C.
|